KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA)

CUSIP: 483119202

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
28,929,479
Total 13F shares
1,734,395
Share change
-1,906,297
Total reported value
$2,653,735
Price per share
$1.53
Number of holders
21
Value change
-$8,492,399
Number of buys
13
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 483119202?
CUSIP 483119202 identifies KALA - KALA BIO, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of KALA - KALA BIO, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Rajeev M. Shah
3/4/5
Director
class O/S missing
10,914,613
$73,564,492 17 Jun 2021
RA CAPITAL MANAGEMENT, L.P.
3/4/5
10%+ Owner
class O/S missing
7,039,613
$47,446,992 26 May 2022
Gregory Grunberg
3/4/5
Director
class O/S missing
5,451,860
$36,745,536 17 Jun 2021
BAKER BROS. ADVISORS LP
13F 3/4/5
Company · Former 10% owner
1.5%
from 3/4/5
1,201,894
$5,721,015 30 Jun 2025
Cormorant Asset Management, LP
13F
Company
2.1%
603,027
$2,870,409 30 Jun 2025
13F
SR ONE CAPITAL MANAGEMENT, LP
13F
Company
2.1%
598,940
$2,850,954 30 Jun 2025
13F
Woodline Partners LP
13F
Company
1%
300,149
$1,428,709 30 Jun 2025
13F
AIGH Capital Management LLC
13F
Company
1%
300,000
$1,428,000 30 Jun 2025
13F
Hongming Chen
3/4/5
CHIEF SCIENTIFIC OFFICER
class O/S missing
204,515
$1,378,431 26 Oct 2021
ADAR1 Capital Management, LLC
13D/G 13F
Company
4.9%
298,955
$1,270,559 $0 31 Dec 2024
VANGUARD GROUP INC
13F
Company
0.59%
170,375
$810,985 30 Jun 2025
13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)
13F
Company
0.48%
138,556
$659,527 30 Jun 2025
13F
Eric Trachtenberg
3/4/5
Chief Legal Officer, Chief Compliance Officer and Secretary
mixed-class rows
88,566
mixed-class rows
$458,765 04 Jan 2024
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.19%
56,367
$268,337 30 Jun 2025
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.19%
55,227
$262,881 30 Jun 2025
13F
BlackRock, Inc.
13F
Company
0.07%
21,356
$101,655 30 Jun 2025
13F
Mark S. Blumenkranz
3/4/5
Director
mixed-class rows
17,517
mixed-class rows
$87,495 11 Jun 2024
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.06%
17,400
$82,824 30 Jun 2025
13F
Andrew I. Koven
3/4/5
Director
mixed-class rows
23,822
mixed-class rows
$68,566 15 Jun 2025
Howard B. Rosen
3/4/5
Director
mixed-class rows
21,952
mixed-class rows
$66,667 15 Jun 2025
XTX Topco Ltd
13F
Company
0.04%
12,990
$61,832 30 Jun 2025
13F
Gregory D. Perry
3/4/5
Director
mixed-class rows
18,794
mixed-class rows
$53,909 15 Jun 2025
NORTHERN TRUST CORP
13F
Company
0.04%
10,399
$49,499 30 Jun 2025
13F
C. Daniel Myers
3/4/5
Director
mixed-class rows
15,824
mixed-class rows
$41,910 15 Jun 2025
Marjan Farid
3/4/5
Director
mixed-class rows
15,692
mixed-class rows
$41,377 15 Jun 2025
Tower Research Capital LLC (TRC)
13F
Company
0%
1,143
$5,441 30 Jun 2025
13F
Covestor Ltd
13F
Company
0%
1,138
$5,000 30 Jun 2025
13F
MORGAN STANLEY
13F
Company
0%
972
$4,627 30 Jun 2025
13F
MAI Capital Management
13F
Company
0%
300
$1,428 30 Jun 2025
13F
Cheviot Value Management, LLC
13F
Company
class O/S missing
153
$1,129 30 Jun 2025
13F
JPMORGAN CHASE & CO
13F
Company
0%
237
$1,128 30 Jun 2025
13F
Steward Partners Investment Advisory, LLC
13F
Company
0%
120
$571 30 Jun 2025
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
100
$476 30 Jun 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
98
$466 30 Jun 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
98
$466 30 Jun 2025
13F
Point72 Asset Management, L.P.
13D/G
0%
257
$393 -$717,340 30 Sep 2025
UBS Group AG
13F
Company
0%
34
$162 30 Jun 2025
13F
Legacy Investment Solutions, LLC
13F
Company
0%
25
$119 30 Jun 2025
13F
Legacy Wealth Managment, LLC/ID
13F
Company
0%
25
$119 30 Jun 2025
13F
SBI Securities Co., Ltd.
13F
Company
0%
8
$38 30 Jun 2025
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
0%
7
$33 30 Jun 2025
13F
Parallel Advisors, LLC
13F
Company
class O/S missing
1
$5 30 Jun 2025
13F
Robert Bradley Paull
3/4/5
Director
class O/S missing
40,000
16 Jun 2022

Institutional Holders of KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) as of Q3 2025

As of 30 Sep 2025, KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,734,395 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, Woodline Partners LP, VANGUARD GROUP INC, ADAR1 Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, BlackRock, Inc., NORTHERN TRUST CORP, UBS Group AG, and Tower Research Capital LLC (TRC). This page lists 21 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
28
Q3 2025 holders
21
Holder diff
-7
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .